Elutia

About:

Elutia is a developer of customized tissue products intended to restore health and mobility to the greatest number of patients.

Website: https://elutia.com

Top Investors: Deerfield, MidCap Financial, SWK Holdings, Nantahala Capital Management, HighCape Partners

Description:

Elutia is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. From our proprietary tissue processing platforms, we have developed a portfolio of advanced regenerative medical products that are designed to be very similar to natural biological material.

Total Funding Amount:

$83M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Silver Spring, Maryland, United States

Founded Date:

2015-01-01

Contact Email:

orders(AT)aziyo.com

Founders:

C. Randal Mills, W. Matthew Zuga

Number of Employees:

101-250

Last Funding Date:

2024-06-17

IPO Status:

Public

Industries:

© 2025 bioDAO.ai